Stockscreener 앱 받기
26.41
3.77%
0.96
시간 외 거래:
26.41
전일 마감가:
$25.45
열려 있는:
$25.6
하루 거래량:
304.10K
Relative Volume:
0.94
시가총액:
$1.18B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-5.27%
1개월 성능:
-1.31%
6개월 성능:
+143.41%
1년 성능:
+29.02%
1일 변동 폭
$25.50
$26.75
1주일 범위
$25.24
$29.00
52주 변동 폭
$4.17
$30.50
Septerna Inc Stock (SEPN) Company Profile
명칭
Septerna Inc
전화
650-338-3533
주소
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO
SEPN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SEPN
Septerna Inc
|
26.41 | 1.14B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-19 | 개시 | Raymond James | Strong Buy |
| 2025-12-15 | 개시 | Truist | Buy |
| 2025-11-14 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-06-23 | 개시 | H.C. Wainwright | Buy |
| 2025-02-18 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-11-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-11-19 | 개시 | JP Morgan | Overweight |
| 2024-11-19 | 개시 | TD Cowen | Buy |
| 2024-11-19 | 개시 | Wells Fargo | Overweight |
모두보기
Septerna Inc 주식(SEPN)의 최신 뉴스
Septerna (NASDAQ:SEPN) Stock Price Down 6.3%What's Next? - MarketBeat
What analysts say about Septerna Inc stockDividend Yield Trends & AI-Based Predictions Available Free - earlytimes.in
Jones Trading initiates coverage of Septerna (SEPN) with buy recommendation - MSN
Jones Trading Initiates Coverage of Septerna (SEPN) with Buy Recommendation - Nasdaq
Septerna stock initiated with Buy rating at Jones Trading on GPCR pipeline By Investing.com - Investing.com South Africa
Septerna stock initiated with Buy rating at Jones Trading on GPCR pipeline - Investing.com Nigeria
Septerna (NASDAQ:SEPN) Coverage Initiated at Jones Trading - MarketBeat
Septerna (SEPN): Valuation Check After Raymond James Buy Rating and S&P Pharma Index Inclusion - Sahm
Septerna, Inc.(NasdaqGM: SEPN) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com
Septerna, Inc.(NasdaqGM: SEPN) added to NASDAQ Biotechnology Index - marketscreener.com
Septerna’s SEP-631 Study: A Potential Game-Changer in Pharmaceutical Research - MSN
Is New Coverage of Septerna (SEPN) Quietly Reframing Its GPCR Platform’s Risk‑Reward Profile? - simplywall.st
Septerna (NASDAQ:SEPN) Coverage Initiated at Raymond James Financial - Defense World
Septerna (NASDAQ:SEPN) Raised to "Strong-Buy" at Raymond James Financial - MarketBeat
Wall Street Zen Upgrades Septerna (NASDAQ:SEPN) to "Strong-Buy" - MarketBeat
Wall Street Zen Upgrades Septerna (NASDAQ:SEPN) to “Strong-Buy” - Defense World
Why Septerna Inc. stock could be next big winner2025 AllTime Highs & Risk Controlled Stock Pick Alerts - Улправда
Septerna Inc stock hits all-time high at 29.79 USD By Investing.com - Investing.com Nigeria
Septerna (NASDAQ:SEPN) Reaches New 12-Month HighShould You Buy? - MarketBeat
Septerna Inc stock hits all-time high at 29.79 USD - Investing.com
Raymond James Initiates Coverage of Septerna (SEPN) with Strong Buy Recommendation - Nasdaq
Raymond James initiates Septerna stock with Strong Buy rating, $38 target - Investing.com Australia
Raymond James Initiates Coverage on Septerna With Strong Buy Rating, $38 Price Target - marketscreener.com
Raymond James initiates Septerna stock with Strong Buy rating, $38 target By Investing.com - Investing.com India
Why Septerna Inc. stock is a must watch in 20252025 Sector Review & Risk Managed Investment Strategies - DonanımHaber
How institutional buying supports Septerna Inc. stockWeekly Earnings Recap & Daily Price Action Insights - Улправда
How Septerna Inc. stock benefits from tech adoptionInsider Selling & Long-Term Investment Growth Plans - Улправда
Septerna, Inc. (NASDAQ:SEPN) Receives $29.25 Average Target Price from Brokerages - Defense World
Septerna (NASDAQ:SEPN) Earns Buy Rating from Analysts at Truist Financial - Defense World
Septerna (NASDAQ:SEPN) Coverage Initiated at Truist Financial - MarketBeat
Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Septerna initiated with a buy at Truist - MSN
Septerna (NASDAQ:SEPN) Trading Up 6.7%Here's Why - MarketBeat
Septerna (SEPN) Receives New "Buy" Rating and $34 Price Target f - GuruFocus
Septerna, Inc. (NASDAQ:SEPN) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Truist Securities initiates Septerna stock with Buy rating on novel drug pipeline By Investing.com - Investing.com South Africa
Truist Securities initiates Septerna stock with Buy rating on novel drug pipeline - Investing.com India
Truist Initiates Septerna at Buy With $34 Price Target - marketscreener.com
Strength Seen in Septerna, Inc. (SEPN): Can Its 7.0% Jump Turn into More Strength? - MSN
Will Septerna Inc. stock continue dividend increasesJuly 2025 Fed Impact & Smart Money Movement Tracker - Newser
Septerna, Inc. $SEPN Shares Sold by Sio Capital Management LLC - MarketBeat
What hedge fund activity signals for Septerna Inc. stockPortfolio Return Summary & Low Drawdown Momentum Ideas - Newser
Novo Nordisk Inks $2.2B Deal With Septerna: Retail’s Thrilled - MSN
Septerna (SEPN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Septerna Inc (SEPN) 재무 분석
Septerna Inc (SEPN)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
28.63%
자본화:
|
볼륨(24시간):